Vithe AI powering healthcare companies that serve more than 190 million people, today announced the release of three State of AI 2026 reports: Health care, BiopharmaceuticalAnd Well-being. These three industry reports provide one of the most comprehensive views yet of how AI is moving from experimentation to artificial intelligence. basic business infrastructure across the global health economy.
Drawing on industry research, emerging architectures and Vi’s work in healthcare companies, the reports reveal a clear trend: AI has surpassed prediction and is now the execution layer— identify frictions, trigger interventions and autonomously carry out multi-step workflows.
In Health careAgentic AI now orchestrates end-to-end operational workflows once managed by large support teams – accelerating the reduction of care gaps, reducing administrative burden, and improving patient activation. Early adopters report 10-20% higher scheduling response, 20-50% reduction in no-shows, and 30-40% increase in documentation. By 2028, more than 80% of routine workflows can be powered by AI.
In BiopharmaceuticalAI is becoming the operational layer of business, medical and clinical functions. Multi-agent orchestration drives 10-35% activation gains for HCPs, 2-3x faster evidence synthesis, 15-30% improvement in buy-in, and 10-20% less enrollment times, reshaping end-to-end lifecycle performance.
In Well-beingAI replaces static programs with continuously adaptive systems. Agent platforms report 3-6x improvements in KPIs, 20-50% reduction in churn, 40-60% reduced support burden, and measurable biometric gains such as +18% deep sleep duration.
“Our industry is moving from experimenting with AI to leveraging it,” said Omri Yoffe, CEO of Vi. “Healthcare operators deploy intelligence capable of predicting, deciding and acting – at scale. »
“At Vi, we believe that key industry lessons and know-how should be shared, not pushed aside. We have structured these reports in a shareable format for real-world applications and will continue to make them accessible on our platforms. If you have a specific use case in mind, simply contact us.”
Vi’s Enterprise AI platform helps leading healthcare organizations drive measurable performance and better healthcare outcomes. Our platform transforms the way businesses activate, engage and operate — transform data science into tangible patient and business ROI through seamless, privacy-friendly, and seamlessly integrated AI orchestration layer.
Today, Vi has a real impact on a national scale:
- 190 million patients and members supported to achieve healthier results
- More than $2 billion in measurable value generated for healthcare, pharmacy and wellness customers
- 50+ Life-Changing Therapies advanced in the fields of oncology, pediatric epilepsy, diabetes, etc.
Vi enables healthcare companies to deliver accuracy, speed and operational excellence with AI they can trust, measure and scale securely.
Headquartered in New York with teams in Tel Aviv, Boston, Austin and Nashville, Vi remains committed to leveraging technology and data science to help people live better, healthier lives.
For more information:
For more information and to access the “State of AI in Biopharma Report,” “State of AI in Healthcare Report,” and “State of AI in Wellbeing Report 2026,” visit Vi